The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in rats
β Scribed by A. M. Koelz; S. Bertschin; M. Hermle; M. Mihatsch; F. P. Brunner; G. Thiel
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 432 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Captopril and enalaprilβangiotensinβconverting enzyme (ACE) inhibitorsβwere evaluated for their antioxidative protective action against adriamycinβinduced cardiac and hepatic toxicity. Rats were treated with either captopril (10 mg kg^β1^) or enalapril (2 mg kg^β1^) intragastrically (i.
Retrospective examination of acute gastrointestinal (GI) lethality in our rat bone marrow transplantation studies showed indication of a protective effect, with a dose modifying factor (DMF) of 1.06 (95% confidence interval: 0.99-1.12). A randomized study, using the same experimental design, was con
Oatp1, the organic anion transport polypeptide, is an integral membrane protein cloned from rat liver that mediates the uptake of various organic anions such as bromosulfophthalein (BSP) and taurocholate (TCA). Recent studies by others revealed that the thrombin inhibitor, CRC 220, a modified dipept